Page last updated: 2024-10-26

ddt and Leukemia, Myeloid

ddt has been researched along with Leukemia, Myeloid in 1 studies

1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane: structure in first source

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research Excerpts

ExcerptRelevanceReference
"DDT-treated rats had a significantly lower mammary tumor incidence, prolonged tumor latency period, and fewer tumors per rat than did the control group."1.25Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats. ( Okey, AB; Silinskas, KC, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silinskas, KC1
Okey, AB1

Other Studies

1 other study available for ddt and Leukemia, Myeloid

ArticleYear
Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats.
    Journal of the National Cancer Institute, 1975, Volume: 55, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; DDT; Drug Synergism; Female; Leukemia

1975